Eremid® Genomic Services is a high complexity CLIA-certified genomics contract research organization, with world-class scientific staff, and cutting-edge genomic instrumentation and automation to create a unique offering to meet the increasing demands for higher data quality, reliability, and accuracy in genomics research.
Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by realizing the potential of breath biomarkers for early detection and precision medicine through Breath Biopsy®. Breath Biopsy provides reliable solutions for the collection and analysis of volatile organic compounds (VOCs) produced through metabolic processes or as a result of interaction with external factors such as diet or medication. Changes to exhaled VOCs can be associated with a range of disease conditions and environmental exposures.
Together with our partners, we create new, visionary products that can shape markets and benefit society. Our game-changing biosolutions solve some of the planet’s biggest challenges. Let’s rethink tomorrow together.
Company description: biocrates life sciences is a global leader in targeted metabolite products and services. Based in Innsbruck, Austria, with a subsidiary in the US, biocrates provides, standardized, quantitative, and FAIR compliant LC-MS/MS based technology covering more than 1000 metabolites. biocrates kit technology is designed for high throughput analyses that are scalable for longitudinal and large cohort studies with a focus on human and animal health, disease, nutrition, and the microbiome.
Bioform solutions has developed a robust assay to monitor the cell health of probiotics, regardless of strains or the matrix. Flow cytometry is a single cell analysis tool. It can enumerate bacteria or yeast, alone or in a mix. It is the only way to enumerate heat killed cells (postbiotics) since they won’t grow. CFUs have been used in the industry for decades due to no extra equipment or knowledge needed, but the data has a 30-50% variability which leads to large questions about its accuracy. It also can only see cells that can grow in a particular media, so mixed strain probiotics can be very problematic. When the cells become stressed out due to processing and packaging, they can become viable but not culturable (VBNC), which means they won’t grow in a CFU assay. Flow cytometry gets around these issues by viewing all of the cells in a product, quickly and accurately with a CV <5%. Flow cytometry takes ~15 minutes whereas the CFU assay takes 3 days. This allows quick decisions to be made as a product is being formulated as well as determining the stability of the products.
HGF is one of Europe’s leading firms of Intellectual Property specialists. The firm is one of only a few to offer a fully integrated IP solution, bringing together patent attorneys, trade mark attorneys, design attorneys, IP solicitors and attorneys-at-law together across 22 offices in seven European countries, including Austria, France, Germany, Ireland, the Netherlands, Switzerland and the United Kingdom.
HGF creates and manages IP portfolios for the world’s leading companies and research institutes. We advise clients on the creation of strategic IP assets around the world and provide world-class expertise in oppositions, appeals, commercialisation, dispute resolution and litigation to defend and enforce IP rights.
We are a dynamic pre-clinical CRO offering the best-in-class in vitro simulations of the gastrointestinal tract to the food, functional food, feed and pharma industry. We offer a broad range of solutions for in vitro simulation of the gastrointestinal tract. Our technology platforms cover the physiology of the upper gastrointestinal tract, the physiology and the microbiology of the lower gastrointestinal tract and the microbiome-host interactions, and range from high-throughput screenings (Colon-on-a-plate®) to in-depth simulation of the long-term impact using the SHIME®.
By sharing our expertise and using our technology platforms, we assist your product development by building up essential know-how in the field of gastrointestinal transit, digestion, bioaccessibility, bioavailability, targeted delivery, drug dissolution, metabolism, microbial fermentation activity, ileal and colonic microbiome, gut barrier integrity, inflammation, immunomodulation and efficacy of probiotics, prebiotics, functional ingredients and pharmaceuticals, in relation to their fate and function in the body.
Recently we expanded our scope with a new business unit, MetaKey®, completely dedicated to metabolomics. In addition to classical UHPLC-HRMS-based untargeted and targeted metabolomics services, MetaKey® offers an innovative LA-REIMS platform for screening based on metabolic fingerprinting, which enables a high throughput at an affordable cost. Applications include analysis of any kind of matrix, but with a particular focus on microbial metabolism and interactions of microbiota with the human body.
A strong team, the desire to innovate and our customers’ satisfaction are at the core of our DNA. Our long-standing expertise and tailor-made solutions support your research from early phases to the final stages of product development. Our long-standing experience and expertise in studying the gastrointestinal processes at your service!
Human Metabolome Technologies (HMT) is a metabolomics profiling company that specializes in pre-clinical and clinical studies. HMT provides both targeted and untargeted profiling metabolite data for a wide range of applications from any sample type. HMT enables clients to understand critical pathways for biomarker discovery, enhance drug development, perform microbiome screening and uncover mechanisms of action through profiling of over 2,000 polar metabolites using high resolution, high performance CE-MS and LC-MS solutions for hundreds of lipophilic metabolites. HMT has been building a best in class metabolite profiling program with over 17 years of service to the research and medical community.
Zymo Research is a globally established biotechnology company and industry leader in the fields of microbiomics, epigenetics, and the emerging Next-Gen Sequencing space. From providing technologically advanced products to validated NGS services, everything is driven by the fundamental belief that "the beauty of science is to make things simple.
Every day, QIAGEN serves 500,000 customers globally, all seeking insights from DNA and RNA. Delivering Sample to Insight solutions for molecular testing, we help scientists and clinicians achieve breakthroughs in life sciences research, molecular diagnostics and drug development. This is how we make improvements in life possible. In healthcare and academic institutions, and drug-discovery and forensic laboratories, QIAGEN solutions advance disease detection and treatments, enable precision medicine, and aid crime detection and human identification.
